Related Experiment Video
Updated: Aug 13, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Barbiturate Induction for the Prevention of Emergence Agitation after Pediatric Sevoflurane Anesthesia
Tadasuke Use1, Haruna Nakahara1, Ayako Kimoto1
1Department of Anesthesiology, Sasebo Kyosai Hospital, Sasebo, Japan.
Insights
Thiamylal induction significantly reduced emergence agitation in pediatric patients after sevoflurane anesthesia. This intravenous barbiturate offers a promising approach to managing post-anesthetic complications in children.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Pharmacology
Background:
- Emergence agitation (EA) is a frequent complication in pediatric patients post-anesthesia.
- Sevoflurane anesthesia is associated with a higher incidence of EA.
- Effective strategies to mitigate EA are crucial for pediatric post-operative care.
Purpose of the Study:
- To evaluate the efficacy of intravenous thiamylal for induction in reducing EA.
- To compare the incidence and severity of EA between thiamylal and sevoflurane induction.
- To assess the impact of thiamylal on pediatric patients recovering from sevoflurane anesthesia.
Main Methods:
- Prospective, randomized, double-blind study involving 54 pediatric patients (1-6 years).
- Two induction groups: intravenous thiamylal 5mg/kg (Group T) vs. inhalational sevoflurane 5% (Group S).
- Anesthesia maintained with sevoflurane and N2O; pain managed with caudal or ilioinguinal blocks. EA assessed using the Modified Objective Pain Scale (MOPS).
Main Results:
- Fifteen minutes post-PACU arrival, EA incidence was significantly lower in Group T (28%) vs. Group S (64%; p=0.023).
- MOPS scores were significantly lower in Group T (median 0) compared to Group S (median 4; p=0.005).
- No significant difference in emergence time between groups.
Conclusions:
- Intravenous thiamylal induction effectively reduces the incidence and severity of emergence agitation.
- Thiamylal is a viable option for pediatric anesthesia induction to improve recovery quality after sevoflurane anesthesia.
- This study supports thiamylal's role in managing post-anesthetic agitation in children.
Objectives:
Emergence agitation (EA) is a common and troublesome problem in pediatric patients recovering from general anesthesia. The incidence of EA is reportedly higher after general anesthesia maintained with sevoflurane, a popular inhalational anesthetic agent for pediatric patients. We conducted this prospective, randomized, double-blind study to test the effect of an intravenous ultra-short-acting barbiturate, thiamylal, administered during induction of general anesthesia on the incidence and severity of EA in pediatric patients recovering from Sevoflurane anesthesia.
Methods:
Fifty-four pediatric patients (1 to 6 years of age) undergoing subumbilical surgeries were randomized into 2 groups. Patients received either intravenous thiamylal 5mg/kg (Group T) or inhalational Sevoflurane 5% (Group S) as an anesthetic induction agent. Following induction, general anesthesia was maintained with Sevoflurane and nitrous oxide (N2O) in both groups. To control the intra- and post-operative pain, caudal block or ilioinguinal/iliohypogastric block was performed. The incidence and severity of EA were evaluated by using the Modified Objective Pain Scale (MOPS: 0 to 6) at 15 and 30 min after arrival in the post-anesthesia care unit (PACU).
Results:
Fifteen minutes after arrival in the PACU, the incidence of EA in Group T (28%) was significantly lower than in Group S (64%; p = 0.023) and the MOPS in Group T (median 0, range 0 to 6) was significantly lower than in Group S (median 4, range 0 to 6; p = 0.005). The interval from discontinuation of Sevoflurane to emergence from anesthesia was not significantly different between the 2 groups.
Conclusions:
Thiamylal induction reduced the incidence and severity of EA in pediatric patients immediately after Sevoflurane anesthesia.
More Related Videos
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
CNS Depressants: Barbiturates and Benzodiazepines
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...